184 related articles for article (PubMed ID: 29369371)
1. Clinical outcomes after upgrading from pacemakers to cardiac resynchronization therapy.
Leyva F; Zegard A; Patel K; Panting J; Marshall H; Qiu T
Pacing Clin Electrophysiol; 2018 Mar; 41(3):290-298. PubMed ID: 29369371
[TBL] [Abstract][Full Text] [Related]
2. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
[TBL] [Abstract][Full Text] [Related]
3. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes.
Jędrzejczyk-Patej E; Mazurek M; Kotalczyk A; Kowalska W; Konieczny-Kozielska A; Kozielski J; Podolecki T; Szulik M; Sokal A; Kowalski O; Kalarus Z; Średniawa B; Lenarczyk R
Europace; 2021 Jan; 23(1):113-122. PubMed ID: 33257952
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy.
Leyva F; Zegard A; Umar F; Taylor RJ; Acquaye E; Gubran C; Chalil S; Patel K; Panting J; Marshall H; Qiu T
Europace; 2018 Nov; 20(11):1804-1812. PubMed ID: 29697764
[TBL] [Abstract][Full Text] [Related]
5. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
[TBL] [Abstract][Full Text] [Related]
6. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
[TBL] [Abstract][Full Text] [Related]
7. Renal function and the long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation.
Leyva F; Zegard A; Taylor R; Foley PWX; Umar F; Patel K; Panting J; Ferro CJ; Chalil S; Marshall H; Qiu T
Pacing Clin Electrophysiol; 2019 Jun; 42(6):595-602. PubMed ID: 30873640
[TBL] [Abstract][Full Text] [Related]
8. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades.
Bogale N; Witte K; Priori S; Cleland J; Auricchio A; Gadler F; Gitt A; Limbourg T; Linde C; Dickstein K;
Eur J Heart Fail; 2011 Sep; 13(9):974-83. PubMed ID: 21771823
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
[TBL] [Abstract][Full Text] [Related]
10. Sex-Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation.
Leyva F; Qiu T; Zegard A; McNulty D; Evison F; Ray D; Gasparini M
J Am Heart Assoc; 2019 Nov; 8(22):e013485. PubMed ID: 31718445
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after upgrade to cardiac resynchronization therapy: A propensity score-matched analysis.
Trenson S; Voros G; Martens P; Ingelaere S; Betschart P; Voigt JU; Dupont M; Breitenstein A; Steffel J; Willems R; Ruschitzka F; Mullens W; Winnik S; Vandenberk B
Eur J Heart Fail; 2024 Feb; 26(2):511-520. PubMed ID: 37905357
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy.
Leyva F; Zegard A; Acquaye E; Gubran C; Taylor R; Foley PWX; Umar F; Patel K; Panting J; Marshall H; Qiu T
J Am Coll Cardiol; 2017 Sep; 70(10):1216-1227. PubMed ID: 28859784
[TBL] [Abstract][Full Text] [Related]
13. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.
Cheung JW; Ip JE; Markowitz SM; Liu CF; Thomas G; Feldman DN; Swaminathan RV; Lerman BB; Kim LK
Heart Rhythm; 2017 Jul; 14(7):1043-1050. PubMed ID: 28214565
[TBL] [Abstract][Full Text] [Related]
14. Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival: Results from a Multicenter Study.
Vamos M; Erath JW; Bari Z; Vagany D; Linzbach SP; Burmistrava T; Israel CW; Duray GZ; Hohnloser SH
Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):e004471. PubMed ID: 28202628
[TBL] [Abstract][Full Text] [Related]
15. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
[TBL] [Abstract][Full Text] [Related]
16. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
18. Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT.
Kosiuk J; Krause M; Doering M; Weber A; Breithardt OA; Dinov B; Darma A; Lucas J; Muessigbrodt A; Bode K; Kuehl M; Dagres N; Hindricks G; Bollmann A; Richter S
Heart Vessels; 2020 Jan; 35(1):104-109. PubMed ID: 31227877
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience.
Schwertner WR; Behon A; Merkel ED; Tokodi M; Kovács A; Zima E; Osztheimer I; Molnár L; Király Á; Papp R; Gellér L; Kuthi L; Veres B; Kosztin A; Merkely B
Europace; 2021 Aug; 23(8):1310-1318. PubMed ID: 34037220
[TBL] [Abstract][Full Text] [Related]
20. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
